Whitehawk Therapeutics, Inc. (WHWK) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-12 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-21 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-13 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-13 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-26 | 8-K | Acquisition or Disposition, Financial Statements & Exhibits | SEC |
| 2025-03-18 | 8-K | Results of Operations, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-03-04 | 8-K | Material Agreement, Shareholder Vote Results, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-20 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-30 | 8-K | Other Events | SEC |
| 2024-09-19 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-08-22 | 8-K | Officer / Director Changes | SEC |
| 2024-08-21 | 8-K | Item 2.05, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-12 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-04 | 8-K | Material Agreement | SEC |
| 2024-03-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.